Cigna Group $CI Position Increased by Douglass Winthrop Advisors LLC

Douglass Winthrop Advisors LLC raised its stake in Cigna Group (NYSE:CI) by 36.1% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 13,344 shares of the health services provider’s stock after buying an additional 3,539 shares during the period. Douglass Winthrop Advisors LLC’s holdings in Cigna Group were worth $3,846,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently modified their holdings of CI. Massachusetts Financial Services Co. MA boosted its stake in shares of Cigna Group by 1.1% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 11,778,472 shares of the health services provider’s stock worth $3,893,727,000 after acquiring an additional 123,479 shares in the last quarter. Dodge & Cox lifted its holdings in shares of Cigna Group by 0.7% during the second quarter. Dodge & Cox now owns 8,950,610 shares of the health services provider’s stock valued at $2,958,893,000 after purchasing an additional 60,877 shares during the last quarter. Norges Bank purchased a new stake in shares of Cigna Group during the second quarter valued at $1,110,426,000. Capital Research Global Investors boosted its position in shares of Cigna Group by 140.2% in the 3rd quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock valued at $916,434,000 after purchasing an additional 1,855,897 shares during the period. Finally, Arrowstreet Capital Limited Partnership increased its stake in Cigna Group by 24.4% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock worth $829,339,000 after purchasing an additional 492,045 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Trading Down 0.6%

Shares of NYSE CI opened at $260.79 on Thursday. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74. Cigna Group has a one year low of $239.51 and a one year high of $350.00. The business has a 50-day moving average price of $280.01 and a two-hundred day moving average price of $283.29. The firm has a market capitalization of $68.73 billion, a PE ratio of 11.76, a PEG ratio of 0.91 and a beta of 0.27.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. The company had revenue of $72.50 billion for the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The firm’s quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, analysts predict that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be paid a $1.56 dividend. The ex-dividend date is Thursday, March 5th. This represents a $6.24 annualized dividend and a yield of 2.4%. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s dividend payout ratio (DPR) is currently 28.13%.

Insider Buying and Selling

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the sale, the insider owned 32,647 shares of the company’s stock, valued at $9,432,044.77. This trade represents a 6.60% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the transaction, the insider owned 5,670 shares in the company, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.70% of the stock is owned by corporate insiders.

Analyst Ratings Changes

CI has been the topic of a number of analyst reports. Deutsche Bank Aktiengesellschaft lifted their price target on Cigna Group from $301.00 to $304.00 and gave the stock a “buy” rating in a research note on Tuesday, February 10th. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Truist Financial lifted their target price on shares of Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a research report on Tuesday, February 17th. Barclays cut their price target on shares of Cigna Group from $305.00 to $303.00 and set an “overweight” rating on the stock in a report on Friday, February 6th. Finally, Zacks Research upgraded shares of Cigna Group from a “strong sell” rating to a “hold” rating in a research report on Monday, January 5th. One analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $330.42.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.